BETTER THERAPEUTICS, INC.

Insiders Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Delayed OTC Markets Other stock markets 10:21:36 2024-05-02 am EDT			5-day change	1st Jan Change
0.0115 ^USD	+2.22%		+91.67%	-94.10%

Mar. 21	Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc	CI
Mar. 20	Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insider Buy: Better Therapeutics	23-07-31	MT
Insider Buy: Better Therapeutics	23-07-31	MT
Better Therapeutics, Inc. Announces Resignation of Suying Liu as Member of the Board of Directors	23-04-14	CI
Insider Buy: Better Therapeutics	23-04-13	MT
Insider Buy: Better Therapeutics	23-04-12	MT
Insider Buy: Better Therapeutics	23-04-12	MT
Insider Buy: Better Therapeutics	23-04-12	MT
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer	22-10-27	CI
Insider Buy: Better Therapeutics	22-09-19	MT
Brii Biosciences Names Chief Technology Officer	22-08-22	MT
Better Therapeutics Hires Former Myovant Sciences CFO Frank Karbe as Chief Executive	22-06-07	MT
Better Therapeutics, Inc. Appoints Frank Karbe as President and as Member of the Board of Directors Starting July 5, 2022	22-06-07	CI
Better Therapeutics Appoints Frank Karbe as Chief Executive Officer Starting July 5, 2022	22-06-07	CI
Insider Buy: Better Therapeutics	21-12-15	MT
Insider Buy: Better Therapeutics	21-12-01	MT
Better Therapeutics, Inc. Appoints Deepti Sodhi Jaggi as Chief Strategy Officer	21-11-30	CI
Better Therapeutics, Inc. Appoints Major General Elder Granger, M.D., U.S. Army to Its Board of Directors	21-11-11	CI
Better Therapeutics, Inc. Appoints Thiago Licias de Oliveira as Its Chief People Officer	21-11-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer